Hold Off on Valentine’s Canoodling

A healthcare professional warns that cold and flu seasons peak in mid-February, so it may be wise take a rain check on kissing, cuddling, and pillow sharing today.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, KOSJorge Parada, medical director of the infectious disease unit at Loyola University Health System, is kind of like an inadvertent anti-cupid. His advice is sound, but it sure isn’t sexy. “Mid-February is usually the peak season for infectious diseases, such as the seasonal and H1N1 flu, mononucleosis, colds, and coughs,” he said in a statement. Instead of kissing, sharing dessert, and cuddling by the fire with that special someone this Valentine’s Day, Parada recommends getting and giving the gift of a flu shot. “It’s the gift that keeps on giving—you protect yourself, your loved one, and you stop the virus from spreading to others,” he said. “If that isn’t sexy, and [doesn’t] say ‘I love you,’ I don’t know what does.”

Flu season around the United States, which started earlier than ever in some regions, is appearing to run its course, having peaked in many spots. Though a cure for the common cold has eluded science thus far, researchers are making strides in understanding the evolution of rhinoviruses, which often cause the temporary illness.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide